Literature DB >> 6102127

The binding of [3H] pargyline to rat liver mitochondrial monoamine oxidase.

D Parkinson, B A Callingham.   

Abstract

The synthesis and purification of tritium labelled N-desmethylpargyline and pargyline are described. The suitability of these irreversible suicide inhibitors of monoamine oxidase (MAO) as ligands in binding studies to rat liver mitochondrial MAO has been evaluated. [3H] Pargyline was found to be more satisfactory than its N-desmethyl analogue because of its greater potency and lower proportion of non-specific binding. The binding of pargyline reached saturation when about 31 pmol mg protein-1 was bound. It was not possible to explain the time course of the binding by either simple first or second-order kinetics. [3H]-Pargyline is a potentially valuable ligand for the estimation of the concentration of NAO active centres without the need to remove the enzyme from the mitochondrial membrane.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6102127     DOI: 10.1111/j.2042-7158.1980.tb12844.x

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  4 in total

1.  Contribution of monoamine oxidase(MAO) to the binding of tertiary basic drugs in isolated perfused rat lung.

Authors:  H Yoshida; K Okumura; R Hori
Journal:  Pharm Res       Date:  1990-04       Impact factor: 4.200

2.  Contribution of monoamine oxidase (MAO) to the binding of tertiary basic drugs in lung mitochondria.

Authors:  H Yoshida; A Kamiya; K Okumura; R Hori
Journal:  Pharm Res       Date:  1989-10       Impact factor: 4.200

3.  Oxidation and enzyme-activated irreversible inhibition of rat liver monoamine oxidase-B by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).

Authors:  K F Tipton; J M McCrodden; M B Youdim
Journal:  Biochem J       Date:  1986-12-01       Impact factor: 3.857

4.  Conventional Receptor Radioligand Binding Techniques Applied to the Study of Monoamine Oxidase.

Authors:  Andrew Holt
Journal:  Methods Mol Biol       Date:  2023
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.